valganciclovir hydrochloride
(VALGANCICLOVIR)Somerset Therapeutics, LLC
Usage: Valganciclovir hydrochloride is indicated for treating cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients. It is also used in pediatric patients aged 1 month to 16 years for CMV disease prevention in transplant scenarios.